MedWorld Advisors acquires stakes in two companies to establish MedTech Laser Group

Recently, MedWorld Advisors, an internationally renowned healthcare M&A consulting firm, is pleased to announce the establishment of a new medical laser company, MedTech Laser Group, by acquiring shares in two similar companies.

The birth of MedTech Laser Group originated from A. in Nuremberg, Germany R. C Laser GmbH and G. from Caesarea, Israel (adjacent to Tel Aviv) N. The successful acquisition of shares in two companies, S. neoLaser Ltd., has received professional guidance and strong support from Afinum Management GmbH in Munich, Germany for this strategic merger.

A. R.C. Laser is a private family owned enterprise that has been deeply involved in the field of medical laser technology since 1996, renowned for its long history and pioneering position in the industry. The company focuses on the field of ophthalmic treatment, especially glaucoma and cataract surgery. Its extensive innovative laser technology solutions have also been extended to multiple surgical application areas such as laryngology, otolaryngology, rhinology, and veterinary medicine, demonstrating its strong research and development capabilities and product diversification capabilities.

On the other hand, neoLaser, founded in 2012, has rapidly emerged as a leader in laser systems and fiber optic technology in recent years, especially in the fields of intravenous laser ablation and proctology. Its cutting-edge laser solutions not only consolidate its market leadership position, but also greatly promote the innovation of patient care and treatment effectiveness.

As an independent investment institution that has been active in the investment field of SMEs since 2000, Afinum focuses on four technology driven vertical fields: healthcare, industrial technology, software and TMT, and consumer and Internet.

Afinum upholds a corporate culture of trust and cooperation, committed to working hand in hand with entrepreneurs to explore and unleash the maximum potential of the enterprise. This transaction is not only the tenth platform investment of Afinum 9 Fund, but also its third important layout in the medical technology field.

In A R. Under the shared vision of the founders of C. Laser and neoLaser, these two leading companies joined forces to establish MedTech Laser Group, with Afinum becoming its major controlling shareholder. The two founders also reinvested in the new entity, demonstrating their firm confidence in the future.

The global ophthalmic and surgical laser market is experiencing unprecedented growth opportunities, thanks to an aging population, increased disease burden, and continuous breakthroughs in laser treatment technology. The establishment of MedTech Laser Group is based on this strategic insight, aiming to grasp the pulse of the market and provide cutting-edge medical solutions.

Under the unified framework of MedTech Laser Group, A.R.C. Laser and neoLaser will work together to share market opportunities and accelerate revenue growth through synergies. Both parties will maintain independent operation while strengthening deep cooperation in research and development, sales, marketing, and regulatory affairs, and jointly promote international expansion and market cultivation. In addition, the group plans to continuously enrich its technology and product portfolio and further consolidate its market position through organic growth and strategic additional acquisitions.

MedWorld Advisors served as the exclusive financial advisor in this transaction, successfully facilitating this unique cross-border collaboration and ensuring that both companies found the ideal partner to support their international expansion while maintaining their respective integrity cultures. As a key strategic investor of the new group, the seller has demonstrated its high recognition and expectations for this partnership and its future development potential.

Source: OFweek